Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $733.4800 (1.75%) ($722.5400 - $733.4800) on Tue. Dec. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.68% (three month average) | RSI | 45 | Latest Price | $733.4800(1.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) DIA(32%) SPLV(29%) IWD(28%) SPY(28%) | Factors Impacting REGN price | REGN will decline at least -0.84% in a week (0% probabilities). TBT(-13%) URA(-6%) ARKG(-5%) VCSH(-4%) ARKK(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.84% (StdDev 1.68%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $745.22 | 5 Day Moving Average | $731.15(0.32%) | 10 Day Moving Average | $742.42(-1.2%) | 20 Day Moving Average | $745.22(-1.58%) | To recent high | -4.3% | To recent low | 7.1% | Market Cap | $77.77b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |